BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Nov 5, 2010
Politics & Policy

Advisory committee votes on ulcer endpoints

BioCentury | Aug 9, 2010
Finance

IPOs Trimmed

Trius, NuPathe price scaled-down IPOs, Complete Genomics, Horizon join the queue
BioCentury | Aug 9, 2010
Finance

Moving on

BioCentury | Aug 3, 2010
Financial News

Horizon files for IPO

BioCentury | May 31, 2010
Clinical News

Duexa ibuprofen/famotidine regulatory update

BioCentury | May 27, 2010
Company News

FDA accepts Duexa NDA

BioCentury | Apr 12, 2010
Company News

Horizon Therapeutics, Nitec deal

BioCentury | Apr 12, 2010
Finance

Merging for an IPO

U.S.-Swiss merger by Horizon, Nitec aims to provide access to U.S. IPO market
Items per page:
1 - 8 of 8